$TECH

AI 分析

生成於 May 11, 2026

AI Score
66/ 100
Hold$TECH

Bio-Techne Corporation

$TECHNASDAQHealthcareMid-Cap

Bio-Techne develops and sells biotechnology instruments and reagents for life science research and clinical diagnostics.

Market Cap
$10.0B
Revenue (TTM)
$1.1B
+3.0%
Net Income (TTM)
$0.2B
+5.0%
EPS (TTM)
$1.25
P/E Ratio
52.0
Dividend Yield
0.3%
52-Week Range
$55-$82
Beta
0.92
Dimension Scores
Fundamental
64
Technical
62
Sentiment
68
Risk / Reward
66
Momentum
64
FundTechSentRiskMome
Financial Health
Profitability
69moderate
Growth
67moderate
Liquidity
74strong
Solvency
66strong
Efficiency
62moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $TECH

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。